Mars Incorporated (“Mars”) today announced that it has entered into an agreement to acquire the assets of SYNLAB Vet, a European provider of specialist veterinary laboratory diagnostics, from SYNLAB Group (FSE: SYAB). Upon transaction close, SYNLAB Vet will join Mars Petcare, a purpose-driven global business serving pets and pet owners through products and services across veterinary health and diagnostics, nutrition, innovation, and technology. This acquisition will enable the Science & Diagnostics division of Mars Petcare to expand its veterinary laboratory business in Europe in addition to its full-service global veterinary diagnostic offerings across veterinary labs, point-of-care, imaging, and software.